FIELD: organic chemistry, medicine, veterinary science, pharmacy.
SUBSTANCE: invention relates to derivatives of tetrahydropyranyl-cyclopentyl-tetrahydropyridopyridine of the formula (1): , wherein R3 means oxygen atom or absent; R8 is chosen from: (a) hydrogen atom; (b) (C1-C3)-alkyl that can be unsubstituted or substituted with 1-6 fluorine atoms; (c) -O-(C1-C3)-alkyl; (d) fluorine atom, and (e) hydroxy-group, and their pharmaceutically acceptable salts and separate diastereomers. These compounds are modulators of activity of chemokine receptors. Also, invention relates to a pharmaceutical composition based on compounds of the formula (1), method for modulation of activity of chemokine receptors in humans and animals and a method for preparing a medicinal agent. Invention provides preparing novel modulators of chemokine receptors activity.
EFFECT: valuable medicinal properties of compounds and pharmaceutical composition.
8 cl, 13 ex
Title | Year | Author | Number |
---|---|---|---|
BENZOXAZINYL-AMIDOCYCLOPENTYL-HETEROCYCLIC MODULATORS OF CHEMOKINE RECEPTORS | 2004 |
|
RU2301802C2 |
SPIROPIPERIDINES, METHODS OF THEIR SYNTHESIS (VARIANTS) | 1993 |
|
RU2168512C2 |
CYCLIC SULPHONAMIDES FOR GAMMA-SECRETASE INHIBITION | 2004 |
|
RU2334743C2 |
SUBSTITUTED MORPHOLINES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF COUNTERACTION TO SUBSTANCE P OR INHIBITION OF NEUROKININ-1 RECEPTORS | 1995 |
|
RU2170233C2 |
DIARYL-5,6-CONDENSED HETEROCYCLIC ACIDS, PHARMACEUTICAL COMPOSITION, AND METHOD OF PROTECTION FROM EFFECTS OF LEUKOTRIENES | 1993 |
|
RU2154065C2 |
SULFONAMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, METHOD OF INHIBITION OF FIBRIN EFFECT AND A METHOD OF TREATMENT OF MAMMALIAN WITH THROMBOSIS | 1992 |
|
RU2116296C1 |
ANTIDIABETIC OXAZOLIDINEDIONES | 2005 |
|
RU2355682C2 |
PHENOXYPHENYL ACETIC ACID | 1994 |
|
RU2139273C1 |
DERIVATIVES OF DIAZEPINE, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT OF PATIENTS WITH ARRYTHMIA | 1994 |
|
RU2155587C2 |
SUBSTITUTED MORPHOLINE DERIVATIVES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON SAID, METHOD OF DECREASE OF TACHIKININ LEVEL IN TREATMENT OR PROPHYLAXIS OF PHYSIOLOGICAL STATES ASSOCIATED WITH TACHIKININ EXCESS | 1994 |
|
RU2131426C1 |
Authors
Dates
2006-10-10—Published
2003-04-25—Filed